Ignite Creation Date:
2024-05-06 @ 1:25 AM
Last Modification Date:
2024-10-26 @ 11:03 AM
Study NCT ID:
NCT01800630
Status:
COMPLETED
Last Update Posted:
2019-07-08
First Post:
2013-02-23
Brief Title:
Phase1 Study of Gemcitabine HCl Oral FormulationD07001-F4 in Patients With Advanced Solid Malignancies and Malignant Lymphomas
Sponsor:
InnoPharmax Inc
Organization:
InnoPharmax Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-04
Start Date Type:
None
Primary Completion Date:
2015-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-03
Completion Date Type:
ACTUAL
First Submit Date:
2013-02-23
First Submit QC Date:
February 25 2013
Study First Post Date:
2013-02-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-07-03
Last Update Post Date:
2019-07-08
Last Update Post Date Type:
ACTUAL